Hepatitis Monthly

Published by: Kowsar

Antifungal Effects of Common Mouthwashes on Candida Strains Colonized in the Oral Cavities of Liver Transplant Recipients in South Iran in 2014

Ali Dehghani Nazhvani 1 , Pardis Haddadi 2 , Parisa Badiee 3 , * , Seyed Ali Malekhoseini 4 and Hadis Jafarian 3
Authors Information
1 Oral and Maxillofacial Pathology Department, Biomaterial Research Center, School of Dentistry, Shiraz University of Medical Sciences, Shiraz, IR Iran
2 Student’s Research Committee, School of Dentistry, Shiraz University of Medical Sciences, Shiraz, IR Iran
3 Professor Alborzi Clinical Microbiology Research Center, Shiraz University of Medical Sciences, Shiraz, IR Iran
4 Organ Transplant Research Center, Shiraz University of Medical Sciences, Shiraz, IR Iran
Article information
  • Hepatitis Monthly: January 01, 2016, 16 (1); e31245
  • Published Online: January 30, 2016
  • Article Type: Research Article
  • Received: July 5, 2015
  • Accepted: December 30, 2015
  • DOI: 10.5812/hepatmon.31245

To Cite: Dehghani Nazhvani A, Haddadi P, Badiee P, Malekhoseini S A, Jafarian H. Antifungal Effects of Common Mouthwashes on Candida Strains Colonized in the Oral Cavities of Liver Transplant Recipients in South Iran in 2014, Hepat Mon. 2016 ; 16(1):e31245. doi: 10.5812/hepatmon.31245.

Copyright © 2016, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Rezvani G, Dehghani Nazhvani A, Motamedi M. Posttransplant lymphoproliferative disorders:A literature review. Shiraz Univ Dent J. 2005; 6(1, 2): 18-25
  • 2. Jin Y, Samaranayake LP, Samaranayake Y, Yip HK. Biofilm formation of Candida albicans is variably affected by saliva and dietary sugars. Arch Oral Biol. 2004; 49(10): 789-98[DOI][PubMed]
  • 3. Pappas PG, Alexander BD, Andes DR, Hadley S, Kauffman CA, Freifeld A, et al. Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin Infect Dis. 2010; 50(8): 1101-11[DOI][PubMed]
  • 4. Mendonca FH, Santos SS, Faria Ida S, Goncalves e Silva CR, Jorge AO, Leao MV. Effects of probiotic bacteria on Candida presence and IgA anti-Candida in the oral cavity of elderly. Braz Dent J. 2012; 23(5): 534-8[PubMed]
  • 5. Badiee P, Kordbacheh P, Alborzi A, Zeini F, Mirhendy H, Mahmoody M. Fungal infections in solid organ recipients. Exp Clin Transplant. 2005; 3(2): 385-9[PubMed]
  • 6. Ahmadieh A, Baharvand M, Fallah F, Djaladat H, Eslani M. Oral microflora in patients on hemodialysis and kidney transplant recipients. Iran J Kidney Dis. 2010; 4(3): 227-31[PubMed]
  • 7. Patel R, Portela D, Badley AD, Harmsen WS, Larson-Keller JJ, Ilstrup DM, et al. Risk factors of invasive Candida and non-Candida fungal infections after liver transplantation. Transplantation. 1996; 62(7): 926-34[PubMed]
  • 8. Mora NP, Klintmalm G, Solomon H, Goldstein RM, Gonwa TA, Husberg BS. Selective amphotericin B prophylaxis in the reduction of fungal infections after liver transplant. Transplant Proc. 1992; 24(1): 154-5[PubMed]
  • 9. Badiee P, Kordbacheh P, Alborzi A, Malekhoseini S, Zeini F, Mirhendi H, et al. Prospective screening in liver transplant recipients by panfungal PCR-ELISA for early diagnosis of invasive fungal infections. Liver Transpl. 2007; 13(7): 1011-6[DOI][PubMed]
  • 10. Lumbreras C, Cuervas-Mons V, Jara P, del Palacio A, Turrion VS, Barrios C, et al. Randomized trial of fluconazole versus nystatin for the prophylaxis of Candida infection following liver transplantation. J Infect Dis. 1996; 174(3): 583-8[PubMed]
  • 11. Olaechea PM, Palomar M, Leon-Gil C, Alvarez-Lerma F, Jorda R, Nolla-Salas J, et al. Economic impact of Candida colonization and Candida infection in the critically ill patient. Eur J Clin Microbiol Infect Dis. 2004; 23(4): 323-30[DOI][PubMed]
  • 12. Traboulsi RS, Mukherjee PK, Ghannoum MA. In vitro activity of inexpensive topical alternatives against Candida spp. isolated from the oral cavity of HIV-infected patients. Int J Antimicrob Agents. 2008; 31(3): 272-6[DOI][PubMed]
  • 13. Ramage G, Jose A, Coco B, Rajendran R, Rautemaa R, Murray C, et al. Commercial mouthwashes are more effective than azole antifungals against Candida albicans biofilms in vitro. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011; 111(4): 456-60[DOI][PubMed]
  • 14. Carvalhinho S, Costa AM, Coelho AC, Martins E, Sampaio A. Susceptibilities of Candida albicans mouth isolates to antifungal agents, essentials oils and mouth rinses. Mycopathologia. 2012; 174(1): 69-76[DOI][PubMed]
  • 15. Shrestha A, Rimal J, Rao A, Sequeira PS, Doshi D, Bhat GK. In vitro antifungal effect of mouth rinses containing chlorhexidine and thymol. J Dent Sci. 2011; 6(1): 1-5[DOI]
  • 16. Mohammadi R, Mirhendi H, Rezaei-Matehkolaei A, Ghahri M, Shidfar MR, Jalalizand N, et al. Molecular identification and distribution profile of Candida species isolated from Iranian patients. Med Mycol. 2013; 51(6): 657-63[DOI][PubMed]
  • 17. Wayne P. Method for broth dilution antifungal susceptibility testing of yeasts: NCCLS document. National Committee for Clinical Laboratory Standards.; 2002;
  • 18. Haddadi P, Zareifar S, Badiee P, Alborzi A, Mokhtari M, Zomorodian K, et al. Yeast colonization and drug susceptibility pattern in the pediatric patients with neutropenia. Jundishapur J Microbiol. 2014; 7(9)[DOI][PubMed]
  • 19. Sganga G, Bianco G, Frongillo F, Lirosi MC, Nure E, Agnes S. Fungal infections after liver transplantation: incidence and outcome. Transplant Proc. 2014; 46(7): 2314-8[DOI][PubMed]
  • 20. Pappas PG, Andes D, Schuster M, Hadley S, Rabkin J, Merion RM, et al. Invasive fungal infections in low-risk liver transplant recipients: a multi-center prospective observational study. Am J Transplant. 2006; 6(2): 386-91[DOI][PubMed]
  • 21. Neville BW. Oral and maxillofacial pathology. 2009;
  • 22. Regezi JA, Sciubba JJ, Jordan RCK. Oral pathology: clinical pathologic correlations. 2012;
  • 23. Al-Mohaya MA, Darwazeh A, Al-Khudair W. Oral fungal colonization and oral candidiasis in renal transplant patients: the relationship to Miswak use. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002; 93(4): 455-60[PubMed]
  • 24. Lopes MM, Barros R, Peres I, Serelha M, Neto MT, Cabrita J, et al. Surveillance of nosocomial fungal infections in a Portuguese paediatric hospital: incidence and risk factors. J Med Mycol. 2006; 16(4): 212-9[DOI]
  • 25. Rezvani G, Davarmanesh M, Azar MR, Salehipour M, Sedaghat R, Karimi F, et al. Oral manifestations of allograft recipients before and after renal transplantation. Saudi J Kidney Dis Transpl. 2014; 25(2): 278-84[PubMed]
  • 26. Chlorhexidine Gluconate Antiseptic Mouthwash Peppermint. 2015;
  • 27. Pappas PG, Kauffman CA, Andes D, Benjamin DK, Jr., Calandra TF, Edwards JE, Jr., et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009; 48(5): 503-35[DOI][PubMed]
  • 28. Diflucan price. 2015;
  • 29. Information on access to drugs at the WHO-negotiated price. 2015;
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments